Peer Review History

Original SubmissionMarch 27, 2023
Decision Letter - Engin Berber, Editor

PONE-D-23-08923Viruses in saliva from sanctuary chimpanzees (Pan troglodytes) in Republic of Congo and UgandaPLOS ONE

Dear Dr. Dunay,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Thank you for submitting your study for publication in PLoS One. We appreciate your confidence in our journal. Your manuscript has undergone extensive review by experts, and while they agree that your study would have a significant impact on the field, they have raised some concerns that require your attention before publication.

We kindly invite you to revise your manuscript and provide a detailed letter that addresses the comments of each reviewer point-by-point. Alternatively, you may raise a rebuttal if you disagree with any of the comments.

Thank you for considering PLoS One for the publication of your research.

Please submit your revised manuscript by Jun 17 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Engin Berber

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met.  

Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. 

Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript.

3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

4. Please expand the acronym “NIH, UW” (as indicated in your financial disclosure) so that it states the name of your funders in full.

This information should be included in your cover letter; we will change the online submission form on your behalf.

5. Thank you for stating the following financial disclosure: 

"This research was supported by National Institutes of Health awards R37AG049395 and R01AG049395 through the National Institute for Aging (https://nia.nih.gov) and the Office of Research on Women's Health (https://orwh.od.nih.gov) to MET, AGR, and TLG and a University of Wisconsin-Madison Global Health Institute (https://ghi.wisc.edu) Graduate Student Research Award to ED. ED was supported by the University of Wisconsin-Madison Comparative Biomedical Sciences Training Grant T32OD010423 from the National Institutes of Health Office of the Director (https://nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

We note that one or more of the authors is affiliated with the funding organization, indicating the funder may have had some role in the design, data collection, analysis or preparation of your manuscript for publication; in other words, the funder played an indirect role through the participation of the co-authors. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please do the following:

(1) Review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. These amendments should be made in the online form.

(2) Confirm in your cover letter that you agree with the following statement, and we will change the online submission form on your behalf: 

“The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.”

6. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

7. We note that Figure 1 in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

(1) You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license.  

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an ""Other"" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

(2) If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

8. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The paper for Dunay and collegues reports on viruses that are detected in saliva from chimpanzees housed in two sanctuaries in Africa, one in the Republic of Congo and the other in Uganda.

In both sanctuaries saliva was collected from 22 and 24 chimpanzees and subsequently analyzed by next generation metagenomic sequencing to document viral diversity in saliva, especially for the presence of viral families that include viruses that can be pathogenic for humans and and be transmitted to humans, especially animal keepers, via bites.

The methods are correct and are standard for this kind of studies. Moreover this is one of the first studies reporting on saliva. The authors identified around 20 viruses from 5 viral families, but none of them is currently associated with pathogenicity in chimpanzees or humans.

I have a few points that need to be clarified:

The authors mention also results on plasma or blood samples rom the same chimpanzee communities, can they specify whether this is also from the same animals for whom saliva samples are studies in this report?

Table 1 seems to contain important information, but the table is truncated and many information is not displayed. This should be rectified!!

The authors should provide more details on the number of reads for the different viruses they reported and the different gene fragments that are obtained. For some viruses , they obtained whole genomes, and for others they did phylogenetic analysis on genes fragments, but how much of the different virus genomes were recovered in the different samples?

Can the authors also provide information on what percentage of the total reads are represented by the viruses reported here, what is percentage of other viruses that were excluded and what was the overall diversity of viruses in saliva.

This can be useful information on whether saliva has a specific virome or whether some viruses are also observed in fecal samples from apes, which are more frequently studied, because these samples are easier to collect.

Reviewer #2: The authors present a manuscript based on the presence of viruses in saliva from african chimpanzees.

This manuscript explain that viruses found in saliva do not cause disease in chimpanzee and human. The authors used phylogenetic analysis for viruses identification and characterisation.

1- The authors have detected viruses in saliva but did not tell about the proviral load for all these viruses. This information is important to best understand the infectiosity of each virus and to best evaluate the risk for transmission to other non human primates and to human.

2- Some bibliographic references number are missed or used in duplicate or triplicate. The authors are requested to use a good logiciel for formating bibliography at the end of the manuscript.

3- Line 267, page 13: What does the sentence means:" Accesssion...this study."

4- Page 16, line 344: What does 70.8% represents? a CI?

5- At the line 419, the authors explain that "primates" include also humans. Is the word "primates" used several time in the manuscript include also "humans" or only animal? If so, the authors are requested to write NHPS and not only "primates".

6- Page 20, line 428: "...has been..." is written twice

Reviewer #3: The present study looks to use metagenomic methods to identify viruses in saliva samples from chimpanzees in two wildlife sanctuaries. I believe the study is interesting, well presented and valuable for practitioners in the field that work in wildlife rehabilitation facilities.

The abstract is succinct, and identifies the uniqueness of the study, as well as clearly summarizes the results and greater implications.

The authors do a great job introducing the subject material and highlighting the importance of the study.

The figures and tables visualize and support the findings well. There is a great number of both as supplementary material.

The methods are well detailed and comprehensively written so that others could repeat the methodology.

The discussion includes limitations and relevant comparisons with previous research. It presents relevant findings, and I believe the conclusions are within the realm of the results.

Minor revision: Please have a look over the reference list as some numbers are missing, repeated or out of order (5 and 6 missing, 21 repeated, 125 comes between 46 and 50).

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Response to Reviewers

**All line numbers reference refer to Revised Manuscript with Track Changes**

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

________________________________________

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: I Don't Know

________________________________________

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

________________________________________

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

________________________________________

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The paper for Dunay and collegues reports on viruses that are detected in saliva from chimpanzees housed in two sanctuaries in Africa, one in the Republic of Congo and the other in Uganda.

In both sanctuaries saliva was collected from 22 and 24 chimpanzees and subsequently analyzed by next generation metagenomic sequencing to document viral diversity in saliva, especially for the presence of viral families that include viruses that can be pathogenic for humans and and be transmitted to humans, especially animal keepers, via bites.

The methods are correct and are standard for this kind of studies. Moreover this is one of the first studies reporting on saliva. The authors identified around 20 viruses from 5 viral families, but none of them is currently associated with pathogenicity in chimpanzees or humans.

I have a few points that need to be clarified:

1 - The authors mention also results on plasma or blood samples rom the same chimpanzee communities, can they specify whether this is also from the same animals for whom saliva samples are studies in this report?

Response to Comment 1: We are grateful to the reviewer for making this suggestion. In order to address the reviewer's critique, we have added information to the Discussion stating whether the same individuals were sampled in the previous plasma manuscript and the current saliva manuscript (lines 444-445).

2 - Table 1 seems to contain important information, but the table is truncated and many information is not displayed. This should be rectified!!

Response to Comment 2: We have followed the PLOS submission guidelines for Tables as listed on the website (https://journals.plos.org/plosone/s/tables), specifically, “Do not split your table or otherwise try to make the table appear within the manuscript margins if it does not fit on one page. In Word, tables that run off of the manuscript page can be seen using Draft View.” If you would like us to submit the table in a different format for better viewing, please advise what is best.

3 - The authors should provide more details on the number of reads for the different viruses they reported and the different gene fragments that are obtained. For some viruses , they obtained whole genomes, and for others they did phylogenetic analysis on genes fragments, but how much of the different virus genomes were recovered in the different samples?

4 - Can the authors also provide information on what percentage of the total reads are represented by the viruses reported here, what is percentage of other viruses that were excluded and what was the overall diversity of viruses in saliva. This can be useful information on whether saliva has a specific virome or whether some viruses are also observed in fecal samples from apes, which are more frequently studied, because these samples are easier to collect.

Response to Comments 3 and 4: We are grateful to the reviewer for making these suggestions. This is indeed useful information. To address these points, we have created additional supporting information tables (S11, S15, and S16). S11 Table (now referenced in line 268) lists for each virus what gene was utilized for phylogenetic analyses and viral abundance calculations, its length, whether the complete or partial gene was obtained, and for which viruses we obtained the complete genome. Additionally, full sequence data (partial or complete genome) for each virus is annotated and available on GenBank (see corresponding accession numbers in Table 1). S15 Table (TCRC) and S16 Table (NICS), both now referenced in lines 366-367, provide the number of reads from each sample that mapped to each virus and what percentage of total reads after quality trim and removal of contaminants/host are viral for each sample. Lastly, as mentioned in the discussion section all types of viruses identified in this study with the exception of papillomaviruses have been documented in the feces of wild chimpanzees (lines 379-382) and one, PtroLCV-1, has been documented in feces from sanctuary chimpanzees at NICS (lines 454-457). This information is further detailed in the S17 Table. Reported viral diversity by ante-mortem sample type for sanctuary chimpanzees in Africa.

Reviewer #2: The authors present a manuscript based on the presence of viruses in saliva from african chimpanzees.

This manuscript explain that viruses found in saliva do not cause disease in chimpanzee and human. The authors used phylogenetic analysis for viruses identification and characterisation.

1- The authors have detected viruses in saliva but did not tell about the proviral load for all these viruses. This information is important to best understand the infectiosity of each virus and to best evaluate the risk for transmission to other non human primates and to human

Response to Comment 1: We thank the reviewer for raising this important point. We agree that it would be useful to understand the infectivity and risk of transmission of these viruses. We have therefore added a statement to the Discussion explaining this idea and how it applies to our study (lines 458-461), and we have provided supporting citations.

2- Some bibliographic references number are missed or used in duplicate or triplicate. The authors are requested to use a good logiciel for formating bibliography at the end of the manuscript.

Response to Comment 2: The reviewer is indeed correct. We have gone through the manuscript with a fine-tooth comb to ensure that all references are properly formatted.

3- Line 267, page 13: What does the sentence means:" Accesssion...this study."

Response to Comment 3: This is an excellent point. This sentence means that the accession number listed in Table 1 is the corresponding GenBank accession number corresponding to the nucleotide sequence of each virus identified in this study. We have changed the wording of this sentence to clarify this point (line 269).

4- Page 16, line 344: What does 70.8% represents? a CI?

Response to Comment: Yes, this represents the upper limit of the 95% confidence interval as defined and indicated throughout the manuscript: (53.3%; 95% confidence interval (CI): 33%, 70.8%).

5- At the line 419, the authors explain that "primates" include also humans. Is the word "primates" used several time in the manuscript include also "humans" or only animal? If so, the authors are requested to write NHPS and not only "primates".

Response to Comment 5: This is indeed a valid point, many thanks. Based on the reviewer's excellent suggestion, we have reviewed the entire manuscript and made changes to reflect appropriate use of “NHP” and “primate” throughout (lines 48 and 433).

6- Page 20, line 428: "...has been..." is written twice

Response to Comment 6: Good catch! We have fixed the typo by removing the duplication (line 432).

Reviewer #3: The present study looks to use metagenomic methods to identify viruses in saliva samples from chimpanzees in two wildlife sanctuaries. I believe the study is interesting, well presented and valuable for practitioners in the field that work in wildlife rehabilitation facilities.

The abstract is succinct, and identifies the uniqueness of the study, as well as clearly summarizes the results and greater implications.

The authors do a great job introducing the subject material and highlighting the importance of the study.

The figures and tables visualize and support the findings well. There is a great number of both as supplementary material.

The methods are well detailed and comprehensively written so that others could repeat the methodology.

The discussion includes limitations and relevant comparisons with previous research. It presents relevant findings, and I believe the conclusions are within the realm of the results.

Response: Many thanks for the positive comments!

Minor revision: Please have a look over the reference list as some numbers are missing, repeated or out of order (5 and 6 missing, 21 repeated, 125 comes between 46 and 50).

Response: We thank the reviewer for raising this important point. To address this point, we have carefully looked over the entire reference list and in-text citations and ensured that numbering is now correct throughout.

________________________________________

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

________________________________________

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Engin Berber, Editor

Viruses in saliva from sanctuary chimpanzees (Pan troglodytes) in Republic of Congo and Uganda

PONE-D-23-08923R1

Dear Dr. Dunay,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Engin Berber

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

Reviewer #3: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Reviewer #3: No

**********

Formally Accepted
Acceptance Letter - Engin Berber, Editor

PONE-D-23-08923R1

Viruses in saliva from sanctuary chimpanzees (Pan troglodytes) in Republic of Congo and Uganda

Dear Dr. Dunay:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Engin Berber

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .